Scott Barraza

Company: PTC Therapeutics

Job title: Discovery Chemistry Group Leader

Seminars:

Next Generation Splicing Modulators 11:15 am

The approval of Risdiplam for the treatment of SMA validated the approach of selectively modulating splicing with small molecules PTC has developed a comprehensive discovery platform to identify novel splicing modulators for the treatment of diseases with unmet needs Novel splicing modulators are being optimized for recently identified disease-relevant splicing eventsRead more

day: Day Two